Clearwater Analytics acquires Enfusion
Today, Clearwater Analytics announced the acquisition of New York Stock Exchange listed financial technology company Enfusion.
With the merger Clearwater Analytics aims to provide the first cloud-native front-to-back platform for the entire investment management industry. Among other things, Enfusion’s front-office capabilities—including IBOR, portfolio and order management—will be integrated with Clearwater’s middle and back-office solutions and client reporting capabilities to enable a unified, cloud-native platform.
The purchase price is $11.25 per share, delivered in an approximately equal mix of cash and stock. Additionally, Clearwater will pay $30 million to terminate Enfusion’s tax receivable agreement (TRA). This equates to a purchase price of approximately $1.5 billion.
The transaction is anticipated to close in Q2 of 2025, subject to approval by Enfusion shareholders, the receipt of required regulatory approvals, and customary closing conditions.